Company / Cash per Share
Oruka Therapeutics, Inc. Cash per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$3.67
FY2024
5-year range
$2.60 / $30.78
FY2020-FY2024
Trend
+41.2%
vs FY2023
Sector context
#54 of 205
Health Care
What the data says
At $3.67, Oruka Therapeutics, Inc.'s cash per share ranks #54 of 205 in the Health Care sector. Cash per Share returned to growth in FY2024 after 3 years of decline, reaching $3.67.
Based on SEC 10-K filings.
3.67 in FY2024 with a 5-year CAGR of -19.4%.
Improved from $2.95 to $3.67 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -13.1%
- 5-Year CAGR
- -19.4%
- 10-Year CAGR
- -
Sector benchmark
#54 of 205 in Health CareTop 26% of 205This company $3.67 Sector average $67.98
▼
-94.6% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 41.2% year-over-year.
- Ranks #54 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $3.67 | +41.2% |
| FY2023 | $2.60 | -11.8% |
| FY2022 | $2.95 | -47.3% |
| FY2021 | $5.59 | -81.8% |
| FY2020 | $30.78 | +184.7% |
| FY2019 | $10.81 | +1362.9% |
| FY2018 | $0.74 | -9.3% |
| FY2017 | $0.81 | -81.0% |
| FY2016 | $4.29 | -15.6% |
| FY2015 | $5.08 | +375.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026